Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000228908 | SCV000616506 | benign | RASopathy | 2017-04-18 | reviewed by expert panel | curation | The filtering allele frequency of the c.3391+7A>G variant in the SOS1 gene is 0.193% (41/16108) of South Asian chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581) |
Laboratory for Molecular Medicine, |
RCV000038550 | SCV000062228 | benign | not specified | 2015-12-22 | criteria provided, single submitter | clinical testing | c.3391+7A>G in intron 21 of SOS1: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence. It has been identified in 0.3% (41/16108) of South Asian chromosomes including one homozygous individual and 0.07% (45/65182) European chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs201982464). |
Gene |
RCV000038550 | SCV000171780 | benign | not specified | 2013-03-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000590714 | SCV000206729 | likely benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000590714 | SCV000227827 | uncertain significance | not provided | 2015-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000228908 | SCV000288966 | benign | RASopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000038550 | SCV000311203 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001094707 | SCV000430419 | likely benign | Noonan syndrome 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000300498 | SCV000430420 | benign | Fibromatosis, gingival, 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590714 | SCV000698634 | benign | not provided | 2017-07-24 | criteria provided, single submitter | clinical testing | Variant summary: The SOS1 c.3391+7A>G variant involves the alteration of a conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 94/118614 control chromosomes (1 homozygote) at a frequency of 0.0007925, which is approximately 26 times the estimated maximal expected allele frequency of a pathogenic SOS1 variant (0.00003), suggesting this variant is likely a benign polymorphism. Ths variant has been reported in affected individual and reported as a "disease-unrelated variant" by authors (Lepri_2011). In addition, multiple clinical diagnostic laboratories/reputable databases recently classified this variant as benign/VUS. Taken together, this variant is classified as benign. |
Genome Diagnostics Laboratory, |
RCV001813358 | SCV002060653 | likely benign | Noonan syndrome and Noonan-related syndrome | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000038550 | SCV002070898 | benign | not specified | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000590714 | SCV004145966 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | SOS1: BS1 |
Genome Diagnostics Laboratory, |
RCV000590714 | SCV001808705 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000590714 | SCV001926874 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000590714 | SCV001970243 | likely benign | not provided | no assertion criteria provided | clinical testing |